WESPAC Advisors’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.02M Sell
18,814
-816
-4% -$47.3K 0.52% 51
2026
Q2
$1.21M Buy
19,630
+216
+1% +$13K 0.59% 45
2026
Q1
$1.14M Sell
19,414
-2,359
-11% -$140K 0.62% 46
2025
Q4
$1.23M Sell
21,773
-300
-1% -$16.4K 0.67% 48
2025
Q3
$1.17M Buy
22,073
+190
+0.9% +$10.3K 0.68% 46
2025
Q2
$1.04M Buy
+21,883
New +$969K 0.72% 43

Other funds holding BTI

WESPAC Advisors's BTI Position: Q3 2026 in Review

WESPAC Advisors reduced its British American Tobacco (BTI) stake by 4.2% in Q3 2026, selling an estimated $47.3K and leaving 18,814 shares worth $1.02M. The position accounts for 0.52% of the portfolio, ranked #51.

WESPAC Advisors first reported a position in BTI in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.23M in Q4 2025. 876 funds tracked by Wall St. Rank hold BTI as of Q3 2026.

  • WESPAC Advisors held 18,814 shares of British American Tobacco worth $1.02M as of Q3 2026.
  • WESPAC Advisors sold 816 British American Tobacco shares in Q3 2026, an estimated $47.3K.
  • British American Tobacco made up 0.52% of WESPAC Advisors's portfolio in Q3 2026, its #51 holding.
  • WESPAC Advisors first reported a position in British American Tobacco in Q2 2025 and has held it in 6 quarters since.
  • WESPAC Advisors's British American Tobacco position peaked at $1.23M in Q4 2025.
  • 876 funds tracked by Wall St. Rank held British American Tobacco as of Q3 2026.

Based on WESPAC Advisors's 13F filing for Q3 2026, filed 26 Oct 2026.